43 Years of Care and Ensuring No One Fights Alone!

General

A Big Win For NF1-PN Patients in Europe

The European Commission has granted conditional approval for EZMEKLY® (mirdametinib) to treat symptomatic, inoperable plexiform neurofibromas (PNs) in patients aged…

Read More

The Champion of the Fall Announced

NF Midwest recently concluded its 2024 Champions of the Fall fundraising campaign, a dedicated effort to support individuals affected by…

Read More

2025 Walk4NF Events

Neurofibromatosis Midwest (NF Midwest) is excited to announce the 2025 Walk4NF events, dedicated to raising awareness and funds for individuals…

Read More

NF Midwest December Update

Check out NF Midwest’s December update. If you are connected with us, you should have received this in an email!…

Read More

Ben’s Trip to Camp

Each year NF Midwest provides the opportunity for families to apply for scholarships for their son or daughter to attend…

Read More

Get the Latest NF News & Updates

Sign up to be notified of new posts to our website.


Visit Us
Follow Me
Tweet
Share